Editorial: Drug development of herbal medicines: Regulatory perspectives
- PMID: 36438850
- PMCID: PMC9686364
- DOI: 10.3389/fphar.2022.989934
Editorial: Drug development of herbal medicines: Regulatory perspectives
Keywords: TCM; ayurveda; botanicals; herbal medicine; regulatory perspectives.
Conflict of interest statement
Author CK was employed by CEO Health Care (Technical), Emami Ltd. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Comment on
- Editorial on the Research Topic Drug development of herbal medicines: Regulatory perspectives
Publication types
LinkOut - more resources
Full Text Sources
